Asherm

PIRS insider buying

Long
Asherm Updated   
NASDAQ:PIRS   Pieris Pharmaceuticals, Inc.
chart looks good and ready to rise but speculative and stop line is maybe too close.
Tread your path
Trade closed: target reached
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.